Evidence map›Paper›PMID 18193362›Full record

ReviewImmunologic research2008

Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection.

Charlotte E Egan, Woraporn Sukhumavasi, Allison L Bierly, Eric Y Denkers

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Ly6CCell reports · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pivotal role of IL-6 in the hyperinflammatory responses to subacute ozone in adiponectin-deficient mice.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  15. Article
  16. Article
  17. Article
  18. TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Charlotte E EganDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401, USA.
Woraporn Sukhumavasi
Allison L Bierly
Eric Y Denkers

Funding

ROLE OF NEUTROPHILS DURING TOXOPLASMOSISR01AI047888 · NIAID · CORNELL UNIVERSITY ITHACA · PI DENKERS, ERIC Y · 2000 to 2008
$3.1M
Immunobiology of Parasitic DiseasesT32AI007643 · NIAID · CORNELL UNIVERSITY ITHACA · PI DENKERS, ERIC Y · 2001 to 2005
$350k
NIAID NIH HHS AI 47888NIAID NIH HHS T32 AI 007643
6 · The paper itself

Abstract

The murine cell surface determinant Gr-1 is expressed at high level on neutrophils. Depletion of polymorphonuclear leukocytes with anti-Gr-1(+) monoclonal antibody results in increased susceptibility and dysregulated immunity to many microbial pathogens, a finding widely interpreted to indicate the importance of neutrophils during infection. Yet, in recent years it has become clear that additional cell types express the Gr-1 determinant, including dendritic cell and monocyte subpopulations. In this review, we evaluate current knowledge on the functional aspects of Gr-1(+) cell populations. We focus on infection with the opportunistic protozoan Toxoplasma gondii, a case where host survival depends on an intact Gr-1(+) cell population.

Indexed as

AnimalsCommunicable DiseasesDendritic CellsImmunity, InnateMiceMonocytesNeutrophilsReceptors, CCR2Receptors, ChemokineToxoplasmosisCcr2 protein, mouseGr-1 protein, mouseReceptors, CCR2Receptors, Chemokine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.